Dr. Blasberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 York Ave
Box #52
New York, NY 10065Phone+1 646-888-2211
Education & Training
- University of California (San Francisco)Residency, Neurology, 1972 - 1974
- New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 1968 - 1969
- New York Presbyterian Hospital (Cornell Campus)Internship, Internal Medicine, 1967 - 1968
- Albert Einstein College of MedicineClass of 1967
Certifications & Licensure
- NY State Medical License 1969 - 2022
- MD State Medical License 1971 - 1980
- PA State Medical License 1971 - 1976
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Imaging Brain Tumors With FACBC and Methionine Start of enrollment: 2003 May 13
- [18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors Start of enrollment: 2009 Jan 01
Publications & Presentations
PubMed
- 35 citationsMolecular Imaging with Reporter Genes: Has Its Promise Been Delivered?Inna Serganova, Ronald G. Blasberg
Journal of Nuclear Medicine. 2019-12-01 - 2713 citationsGraphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data:Clifford S. Patlak, Ronald G. Blasberg, Joseph D. Fenstermacher
Journal of Cerebral Blood Flow and Metabolism. 1983-03-01 - 630 citationsTumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hostsSergio A. Quezada, Tyler R. Simpson, Karl S. Peggs, Taha Merghoub, Jelena Vider
The Journal of Experimental Medicine. 2010-03-15
Journal Articles
- LDH-A Regulates the Tumor Microenvironment via HIF-Signaling and Modulates the Immune ResponseRonald Blasberg, Jason A Koutcher, PLoS One
Grant Support
- Mskcc Center For Molecular Imaging In CancerNational Cancer Institute2006–2011
- Organization And AdministrationNational Cancer Institute2008–2010
- Imaging T Cell Interactions In Adoptive Therapy Of Ebv-Associated MalignanciesNational Cancer Institute2008–2010
- Career Development ProgramNational Cancer Institute2008–2010
- Imaging CoreNational Cancer Institute2006–2010
- Imaging Signaling Changes In Cancer And TreatmentNational Cancer Institute2004–2008
- Imaging Brain Tumors With FacbcNational Cancer Institute2003–2004
- Imaging Transgene Expression In Gene Therapy ProtocolsNational Cancer Institute2002–2004
- Mskcc Center For In Vivo Molecular Imaging In CancerNational Cancer Institute2000–2002
- Core--Quantitative Autoradiographic &Optical ImagingNational Cancer Institute2000–2002
- Core--Mskcc FacilitiesNational Cancer Institute2000–2002
- Core--Molecular Biology &Vector DevelopmentNational Cancer Institute2000–2002
- Core--Imaging FacilityNational Cancer Institute2000–2002
- Core--Development ProjectsNational Cancer Institute2000–2002
- Core--Career Development ProgramNational Cancer Institute2000–2002
- Early Assessment Of Cytostatic Drug ResponseNational Cancer Institute1999–2000
- Imaging Gene Transfer And ExpressionNational Cancer Institute1997–1999
- IUDR Imaging Of Tumor ProliferationNational Cancer Institute1997–1998
- Brain Tumor Imaging With Nonmetabolized Amino AcidsNational Cancer Institute1994–1996
- Imaging Tumor Proliferation With 124i-IododeoxyuridineFogarty International Center1995
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: